Showing results (521-530 of 777) with videos related to

Sort By:
Pageof 78
Cancers|May 13, 2026
Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588Brett Berezowski, Robert Boothe, Billy Chaplin, et al.
Urology|February 29, 2008
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomyDavid J Hernandez, Matthew E Nielsen, Misop Han, et al.
Urology|July 3, 2003
Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigenTheresa Y Chan, Stephen D Mikolajczyk, Kristin Lecksell, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
The Journal of Urology|March 23, 2011
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Edward M Schaeffer, et al.
The Journal of Urology|August 17, 2018
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active SurveillanceSasha C Druskin, Mufaddal Mamawala, Jeffrey J Tosoian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomyEli Rosenbaum, Mohammad Obaidul Hoque, Yoram Cohen, et al.
The American Journal of Surgical Pathology|November 17, 2022
Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and MorphologyLin Li, Sean R Williamson, Rosa P Castillo, et al.
The American Journal of Dermatopathology|November 2, 2021
Poorly Differentiated Scrotal Carcinoma With Apocrine ImmunophenotypeSonia Kamanda, Jonathan I Epstein, Adeboye O Osunkoya, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2022
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomyMatthew J Roberts, Andrew Morton, Nathan Papa, et al.
Pageof 78